< Back to latest news & events

Knowledge Hub

Agreement reached on the distribution of renewal fees in respect of Unitary Patents

November 2015

Agreement has been reached on the distribution of income that will be generated from renewal fees in respect of Unitary Patents. The EPO will be entitled to 50% of each renewal fee, while the other 50% will be distributed among the EU Member States participating in the Unitary Patent scheme, announced the EPO.

Within the announcement, the EPO President stated we could expect to see Unitary Patents as soon as mid 2016: “For its own part, the EPO is ready to implement the system. Provided that the EU Member States manage to ratify the Agreement establishing the Unified Patent Court in time, the first Unitary Patents could already be delivered in the second half of 2016”.

A separate announcement for the European Commission explained further that “50% of fees will be retained by the EPO while the remainder (minus an administrative charge) will be distributed among the participating countries according to a formula that takes account of the GDP and the number of applications filed from that country. The distribution arrangements will be reviewed regularly. The EPO will report on revenues and the fee distribution, and it will be possible, though not obligatory, to adapt the distribution key if practice differs greatly from projected figures. The distribution key will be subject to revision every five years.”

The Unitary Patent renewal fees have been already set a level roughly equivalent to what an applicant would normally pay for the four major countries under the classical European patent system. Since Italy acceded to the Unitary Patent Package on 30 September, this fee level has become more attractive.

Latest updates

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article